Search Press releases Keywords From To 2 Mar 2010 UCB: Solid foundation for sustainable growth Read More 29 Jan 2010 UCB accelerates transition to become patient-centric global biopharmaceutical leader with decision to exit the primary care market in the U.S. Read More 21 Dec 2009 UCB announces initial clinical trial results involving patients taking certolizumab pegol for moderate to severe Crohn's disease Read More 15 Dec 2009 UCB signs a new EUR 1.5 billion credit facility Read More 3 Dec 2009 UCB completes the placement of 7-year bonds Read More 3 Dec 2009 UCB launches offering of 7-year bonds Read More Pagination First page Previous page Previous … Page 161 Page 162 Page 163 Page 164 Current page 165 Page 166 Page 167 Page 168 Page 169 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
